THALLOUS CHLORIDE TL 201
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
THALLOUS CHLORIDE TL 201 by GE HealthCare is 201 with no carrier added accumulates in viable myocardium in a manner analogous to that of potassium. First approved in 1982.
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Thallous Chloride Tl 201 is a radioactive diagnostic imaging agent used to assess myocardial perfusion and detect coronary artery disease. It accumulates in viable myocardium analogously to potassium and correlates with regional blood flow, visualizing areas of infarction as 'cold' regions and transient ischemia during stress testing. The product enables non-invasive evaluation of cardiac viability and coronary stenosis severity.
LOE Approaching
Product approaching end-of-life with limited commercial growth prospects; brand teams are typically focused on cost management and transition planning rather than expansion.
Mechanism of Action
201 with no carrier added accumulates in viable myocardium in a manner analogous to that of potassium. Experiments in healthy subjects using labeled microspheres have shown that the myocardial distribution of thallous chloride Tl 201 correlates with regional perfusion. In clinical studies, Thallous…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Work on Thallous Chloride Tl 201 offers limited career acceleration given the product's mature, approaching LOE status and zero linked job openings. This role is suitable for professionals seeking stable, compliance-focused diagnostic portfolio experience rather than growth-stage innovation exposure.
Worked on THALLOUS CHLORIDE TL 201 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.